Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc. (SUPN)
Filing Type: Form 8-K (Current Report)
Date of Report: February 25, 2021
Reporting Period: Fourth quarter and full year ended December 31, 2020
This filing serves as a notification that the Company issued a press release regarding its financial results for the fourth quarter and full year ended December 31, 2020. The detailed financial data is contained in Exhibit 99.1 (Press Release), which is incorporated by reference but not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the period ended December 31, 2020.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The Company hosted a conference call on February 25, 2021, to present business and financial results. The filing contains standard forward-looking statements regarding plans, strategies, and intentions, noting that these are subject to risks and uncertainties.
Risks and Contingencies: The filing explicitly references risk factors detailed in previous filings, including:
- Annual Report on Form 10-K for the fiscal year ended December 31, 2019.
- Current Report on Form 8-K filed on April 3, 2020.
- Quarterly Reports on Form 10-Q filed on May 15, 2020, and August 17, 2020.
The Company undertakes no obligation to update forward-looking statements except as required by federal securities laws.
Investor Verification Checklist
- Exhibit 99.1: Review the attached press release for specific Q4 and full-year 2020 financial figures (revenue, net loss, cash position).
- Conference Call: Verify the transcript or webcast archive for management's commentary on the results and future outlook.
- Risk Factors: Consult the referenced 10-K and 10-Q filings for a comprehensive list of risks affecting the Company's operations.
- Legal Status: Note that the financial information in this 8-K is "furnished" and not "filed," limiting liability under Section 18 of the Exchange Act.